Faculty of Pharmacy

1.5 million PLN for the implementation of Dr. hab. Monika Marcinkowska’s project

Dr. hab. Monika Marcinkowska has become a laureate of the INNOGLOBO 4 competition organized by the National Centre for Research and Development. The “drug repurposing” project titled “A New Approach to Pharmacotherapy of Post-Stroke Apathy – Development of an Innovative Medicinal Product,” led by Jagiellonian University Medical College (UJ CM), received funding of 1.5 million Polish zlotys and will be implemented in cooperation with a Belgian pharmaceutical company.

The INNOGLOBO program enables Polish entities to establish research and development cooperation (in various thematic areas) with foreign partners from countries with which Poland maintains diplomatic relations.

Within the framework of the competition, applicants can obtain funding for the implementation of international projects with diverse budgets, covering various thematic areas, including niche ones. The requirements for competition applications are the participation of at least one foreign partner in the project and the thematic scope of the project fitting into the current List of National Smart Specializations.

– The aim of the project is to develop an innovative medicinal product containing a repositioned drug, which will be adapted to the specific needs of patients with post-stroke apathy. This is a common consequence of stroke affecting a significant percentage of patients, which translates into millions of people worldwide affected by this disorder. The lack of effective pharmacotherapy methods makes this condition a huge burden for healthcare systems and families caring for patients. Therefore, the development of effective therapies for post-stroke apathy remains a key medical and social challenge of global importance – explains the researcher.

Dr. hab. Monika Marcinkowska is associated with the Department of Pharmaceutical Chemistry at Jagiellonian University Medical College (Faculty of Pharmacy) and serves as the Deputy Director for Scientific Affairs at the Centre for the Development of Therapies for Civilizational and Age-Related Diseases.

A graduate of the Faculty of Pharmacy at Jagiellonian University Medical College, she obtained her PhD from the Politecnico di Milano in 2009. She participated in short- and long-term scientific internships at foreign centers (three-year doctoral studies at the Politecnico di Milano, a six-month Erasmus scholarship at Utrecht University, and a five-month stay at the University of Valencia).

She is a co-author of five patent applications and one patent in the field of searching for original biologically active molecules, which were developed in cooperation with the pharmaceutical company Adamed. She led three research projects financed by the National Science Centre (Sonata, Sonata Bis) and the Foundation for Polish Science (Inter).

Her scientific work broadly concerns research into the search for new biologically active molecules with the aim of obtaining new drug candidates that, by interacting with biological targets closely related to the pathology of diseases, have a chance for high therapeutic effectiveness.

She has been repeatedly honored for her publication achievements and has also received the Polish Intelligent Development Award and an award for an oral presentation from the Polish Pharmaceutical Society.

Since 2018, she has been involved in creating the substantive concept of the Centre for the Development of Therapies for Civilizational and Age-Related Diseases (CDT-CARD) at Jagiellonian University Medical College, co-creating the application for the inclusion of CDT-CARD in the Polish Roadmap for Research Infrastructure.

In November last year, the researcher received the Prime Minister’s Award in the category of highly rated scientific achievements forming the basis for conferring the habilitation degree.



Back


Accessibility by WAH